#weight-loss-medications

[ follow ]
#glp-1-receptor-agonists #type-2-diabetes #glp-1-drugs #glp-1 #wegovy-safety #eye-stroke-risk #vision-loss
Medicine
fromIndependent
14 hours ago

Weight-loss jab Wegovy has 'highest risk of rare eye stroke', study finds

Wegovy carries nearly five times higher risk of eye stroke and sudden sight loss compared to Ozempic, with men facing three times greater risk than women.
#glp-1-receptor-agonists
fromwww.scientificamerican.com
1 month ago
Medicine

The next wave of GLP-1 drugs are comingand they're stronger than Wegovy and Zepbound

New multi-target GLP‑1 and related obesity drugs can produce substantial weight loss for many users, but effectiveness varies, gray-market use grows, and safety concerns remain.
fromwww.scientificamerican.com
2 months ago
Medicine

Weight and Health Benefits Vanish Fast after Quitting Weight-Loss Drugs, Study Finds

Stopping GLP-1 and other weight-loss drugs typically leads to rapid weight regain and loss of heart-health benefits within two years.
Medicine
fromwww.theguardian.com
21 hours ago

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds

Wegovy users have nearly five times higher risk of sudden vision loss compared to Ozempic users, with risk appearing dose-dependent and higher in men.
more#glp-1-receptor-agonists
Medicine
fromwww.bbc.com
5 days ago

Relying on drugs to stop obesity would be 'societal failure', says Chris Whitty

Relying on weight-loss drugs like Wegovy and Mounjaro to address obesity represents a societal and medical failure; prevention through healthy eating and lifestyle changes should be prioritized instead.
Medicine
fromIndependent
1 month ago

Are people spending less on food when they take weight-loss drugs?

Some individuals who can afford costly weight-loss medications may reduce household grocery spending significantly, offsetting part of the medication cost.
#glp-1-drugs
more#glp-1-drugs
Medicine
fromThe Atlantic
3 months ago

A New Class of Drugs Is Pushing the Limits of Weight Loss

New amylin-based and combined amylin–GLP-1 drugs can produce greater weight loss with fewer bothersome side effects, expanding medical obesity treatment options.
Public health
fromwww.theguardian.com
3 months ago

Crime gangs in UK start making own branded weight-loss drugs

Organised crime now manufactures branded, counterfeit weight-loss drugs with professional packaging and unlicensed active ingredients, posing a major public-safety and enforcement threat.
fromwww.mediaite.com
4 months ago

JUST IN: Trump Announces Big Pharma Discounts of Weight Loss Drugs Ozempic and Zepbound

During a press conference in the Oval Office and surrounded by many of his most senior aides, including HHS Secretary Robert Kennedy, Jr, and Dr. Mehmet Oz, Trump revealed that two of the world's largest pharmaceutical manufacturers, Eli Lilly and Novartis, will offer weight loss drugs at drastic discounts. So far, never heard anything bad about them, only good about them, Trump ad libbed from his prepared remarks before asking his Kennedy, Is there anything bad about them, Bobby?
US politics
Science
fromBBC
4 months ago

Witness History - GLP-1: A breakthrough for diabetes and obesity - BBC Sounds

Svetlana Mojsov discovered GLP-1 in the 1980s, enabling development of GLP-1–based treatments for type 2 diabetes and later for weight loss.
[ Load more ]